BIOVENTUS INC. (BVS) EBITDA
- 2026-06-27: Basis Reported; EBITDA $30.07M*; Operating income $19.13M; Depreciation and amortization $10.95M*.
- 2026-03-28: Basis Reported; EBITDA $19.62M; Operating income (m); Depreciation and amortization (m).
- 2025-12-31: Basis Reported; EBITDA $31.18M; Operating income (m); Depreciation and amortization (m).
- 2025-09-27: Basis Reported; EBITDA $22.66M*; Operating income $11.25M; Depreciation and amortization $11.40M*.
Complete source-backed ebitda history.
- Available history
- 2019-12-31 to 2026-03-28
- Data captured
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-27 | Reported | $30.07M* | $19.13M | $10.95M* | $153.21M | 19.63%* | $960.00K* | $19.87M* | $47.54M | $3.17M | $82.74M | -$20.90M |
|---|
| 2026-03-28 | Reported | $19.62M | (m) | (m) | (m) | 14.85% | $574.00K | $8.93M | $41.32M | $2.47M | $78.33M | $571.00K |
|---|
| 2025-12-31 | Reported | $31.18M | (m) | (m) | (m) | 19.75% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2025-09-27 | Reported | $22.66M* | $11.25M | $11.40M* | $138.65M | 16.34%* | $473.00K* | $30.10M* | $44.42M | $2.92M | $78.66M | $664.00K |
|---|
| 2025-06-28 | Reported | $30.42M* | $18.37M | $12.05M* | $147.66M | 20.60%* | $683.00K* | $25.94M* | $45.57M | $3.17M | $79.11M | $1.04M |
|---|
| 2025-03-29 | Reported | $16.73M | (m) | (m) | (m) | 13.51% | $826.00K | -$19.33M | $40.82M | $3.01M | $73.50M | -$95.00K |
|---|
| 2024-12-31 | Reported | $20.11M | (m) | (m) | (m) | 13.09% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2024-09-28 | Reported | $15.92M* | $3.65M | $12.28M* | $138.96M | 11.46%* | $64.00K* | $10.32M* | $45.41M | $3.84M | $81.48M | $589.00K |
|---|
| 2024-06-29 | Reported | -$18.38M* | -$31.47M | $13.09M* | $151.22M | -12.16%* | $77.00K* | $15.16M* | $47.58M | $4.21M | $96.67M | -$7.34M |
|---|
| 2024-03-30 | Reported | $16.71M | (m) | (m) | (m) | 12.91% | $291.00K | -$6.00M | $41.08M | $2.63M | $78.78M | $907.00K |
|---|
| 2023-12-31 | Reported | $13.63M | (m) | (m) | (m) | 10.06% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2023-09-30 | Reported | $16.25M* | $2.42M | $13.83M* | $120.79M | 13.45%* | $2.04M* | -$8.31M* | $41.94M | $3.02M | $69.82M | $600.00K |
|---|
| 2023-07-01 | Reported | $21.35M* | $6.75M | $14.60M* | $137.07M | 15.58%* | $1.40M* | $10.79M* | $47.95M | $3.40M | $74.84M | $381.00K |
|---|
| 2023-04-01 | Reported | -$75.59M | (m) | (m) | (m) | -63.49% | $3.56M | $2.49M | $45.14M | $3.77M | $80.86M | -$146.00K |
|---|
| 2022-12-31 | Reported | $1.31M | (m) | (m) | (m) | 1.04% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2022-10-01 | Reported | -$113.25M* | -$126.84M | $13.59M* | $128.66M | -88.02%* | $1.65M* | -$701.00K* | $44.13M | $4.61M | $78.95M | -$29.52M |
|---|
| 2022-07-02 | Reported | $9.08M* | -$3.31M | $12.38M* | $140.33M | 6.47%* | $2.03M* | $2.94M* | $43.68M | $6.37M | $89.62M | $1.24M |
|---|
| 2022-04-02 | Reported | -$8.97M | (m) | (m) | (m) | -7.65% | $2.96M | -$21.02M | $41.59M | $6.93M | $86.12M | -$5.13M |
|---|
| 2021-12-31 | Reported | $8.54M | (m) | (m) | (m) | 6.55% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2021-10-02 | Reported | $7.47M* | -$1.05M | $8.52M* | $108.89M | 6.86%* | $1.93M* | $10.59M* | $29.82M | $6.15M | $69.64M | -$882.00K |
|---|
| 2021-07-03 | Reported | $1.74M* | -$5.74M | $7.48M* | $109.82M | 1.58%* | $1.27M* | $17.33M* | $33.50M | $4.84M | $69.05M | $1.71M |
|---|
| 2021-04-03 | Reported | $29.18M | (m) | (m) | (m) | 35.68% | $1.37M | -$18.04M | $22.22M | $947.00K | $34.69M | -$73.00K |
|---|
| 2020-12-31 | Reported | $12.76M | (m) | (m) | (m) | 12.94% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2020-09-26 | Reported | $14.21M* | $6.93M | $7.28M* | $85.91M | 16.54%* | $1.28M* | $20.84M* | $23.44M | $3.57M | $50.30M | $373.00K |
|---|
| 2020-06-27 | Reported | $2.65M* | -$4.59M | $7.25M* | $58.02M | 4.58%* | $751.00K* | $7.82M* | $17.67M | $2.60M | $40.53M | -$110.00K |
|---|
| 2020-03-28 | Reported | $20.25M | (m) | (m) | (m) | 25.75% | $299.00K | $17.69M | $21.41M | $2.15M | $40.28M | $39.00K |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-12-31 | Reported | $100.99M | (m) | (m) | (m) | 17.78% | $2.56M | $74.67M | $179.93M | $12.11M | $314.03M | -$1.56M |
|---|
| 2024-12-31 | Reported | $34.36M | (m) | (m) | (m) | 5.99% | $1.01M | $38.80M | $185.05M | $13.95M | $343.80M | -$5.29M |
|---|
| 2023-12-31 | Reported | -$24.36M | (m) | (m) | (m) | -4.75% | $7.36M | $15.34M | $184.15M | $13.45M | $303.88M | $85.00K |
|---|
| 2022-12-31 | Reported | -$111.84M | (m) | (m) | (m) | -21.84% | $1.48M | -$13.54M | $181.04M | $23.85M | $332.13M | -$44.37M |
|---|
| 2021-12-31 | Reported | $46.94M | (m) | (m) | (m) | 10.89% | $13.52M | $22.99M | $128.19M | $19.04M | $254.25M | -$1.97M |
|---|
| 2020-12-31 | Reported | $49.88M | (m) | (m) | (m) | 15.53% | $16.58M | $71.80M | $87.64M | $11.20M | $193.08M | $1.19M |
|---|
| 2019-12-31 | Reported | $61.51M | (m) | (m) | (m) | 18.08% | $2.34M | $40.71M | $90.94M | $11.05M | $198.47M | $1.58M |
|---|